Details
Stereochemistry | EPIMERIC |
Molecular Formula | C19H27ClN2O5 |
Molecular Weight | 398.881 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)CC(NC(=O)[C@@H](NC(=O)OC(C)C)C(C)C)C1=CC=C(Cl)C=C1
InChI
InChIKey=DBXFMOWZRXXBRN-LWKPJOBUSA-N
InChI=1S/C19H27ClN2O5/c1-11(2)17(22-19(25)27-12(3)4)18(24)21-15(10-16(23)26-5)13-6-8-14(20)9-7-13/h6-9,11-12,15,17H,10H2,1-5H3,(H,21,24)(H,22,25)/t15?,17-/m0/s1
Molecular Formula | C19H27ClN2O5 |
Molecular Weight | 398.881 |
Charge | 0 |
Count |
|
Stereochemistry | EPIMERIC |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL613063 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25286613 |
|||
Target ID: GO:0030244 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:45:54 GMT 2023
by
admin
on
Sat Dec 16 18:45:54 GMT 2023
|
Record UNII |
S4BR27QQ5S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID6058051
Created by
admin on Sat Dec 16 18:45:54 GMT 2023 , Edited by admin on Sat Dec 16 18:45:54 GMT 2023
|
PRIMARY | |||
|
S4BR27QQ5S
Created by
admin on Sat Dec 16 18:45:54 GMT 2023 , Edited by admin on Sat Dec 16 18:45:54 GMT 2023
|
PRIMARY | |||
|
valifenalate
Created by
admin on Sat Dec 16 18:45:54 GMT 2023 , Edited by admin on Sat Dec 16 18:45:54 GMT 2023
|
PRIMARY | |||
|
11338509
Created by
admin on Sat Dec 16 18:45:54 GMT 2023 , Edited by admin on Sat Dec 16 18:45:54 GMT 2023
|
PRIMARY | |||
|
283159-90-0
Created by
admin on Sat Dec 16 18:45:54 GMT 2023 , Edited by admin on Sat Dec 16 18:45:54 GMT 2023
|
PRIMARY |